| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-743 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-34 |
| filingDate |
2015-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6fa98c9e65cb715839a52935e2c9d1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1882abe6c47002e176771ef53e5c34c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b87cca121f5e88b17d248c61e8ffeb7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d73bbe7a860208f6d0153284a837f0c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c936ddafa60eb263b7b4f66290c058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce31025052aac1e64b1aa3603c3afe5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c63e710eeb8d7bf9c8fa623f095fc67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aefd131e941124c5b31807490c10763 |
| publicationDate |
2017-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017320802-A1 |
| titleOfInvention |
Polyprenylated phloroglucinol compounds as potent p-glycoprotein inducers |
| abstract |
The present invention relates to the polyprenylated phloroglucinol compounds of formulae I and II. The present invention also provides synthesis and p-glycoprotein induction activity of the alkyl- and acyl-polyprenylated phloroglucinol compounds. Further, use of the compounds as p-glycoprotein inducers and methods of treatment of Alzheimer's disease using compounds of the invention are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022254465-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018325841-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11096906-B2 |
| priorityDate |
2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |